Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 17, 2005

Hypertension. 2005
Published online before print January 17, 2005, doi: 10.1161/01.HYP.0000154822.37141.f6
A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/3/412    most recent
01.HYP.0000154822.37141.f6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verdecchia, P.
Right arrow Articles by Porcellati, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verdecchia, P.
Right arrow Articles by Porcellati, C.
Related Collections
Right arrow Congestive
Right arrow Hypertrophy
Right arrow Clinical Studies
Right arrow Echocardiography
Right arrow Epidemiology

Submitted on November 20, 2004
Revised on December 9, 2004

Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension, Prevalence, Determinants, and Prognostic Value

Paolo Verdecchia*; Fabio Angeli; Roberto Gattobigio; Mariagrazia Sardone; and Carlo Porcellati

From the Department of Cardiovascular Disease (P.V., F.A., M.S., C.P.), R. Silvestrini Hospital, Perugia; and Division of Medicine (R.G.), Beato G. Villa Hospital, Città della Pieve, Italy.

* To whom correspondence should be addressed. E-mail: verdec{at}tin.it.

Abstract--Prevalence, determinants, and prognostic value of asymptomatic left ventricular systolic dysfunction (LVSD) in uncomplicated subjects with essential hypertension are still incompletely known. We studied 2384 initially untreated subjects with hypertension, no previous cardiovascular disease, and no symptoms or physical signs of congestive heart failure (CHF). These subjects were studied at entry and followed for up to 17 years (mean 6.0). Asymptomatic LVSD (ALVSD), defined by an echocardiographic ejection fraction <50%, was found in 3.6% of subjects. Cigarette smoking (P=0.013), increased left ventricular (LV) mass (P=0.001), and higher 24-hour heart rate (P=0.014) were independent correlates of ALVSD. During follow-up, a first cardiovascular event occurred in 227 subjects, and 24 of these events were hospitalizations for symptomatic CHF. Incidence of CHF per 100 persons per year was 0.12 in patients without and 1.48 in patients with ALVSD (log-rank test P=0.0001). In a Cox model, after adjustment for age (P=0.0001), LV mass (P=0.0001), and cigarette smoking (P=0.039), LVSD conferred a markedly increased risk for CHF (odds ratio, 9.99; 95% confidence interval, 3.67 to 27.2). Incidence of coronary (0.84 versus 0.62x100 person years) and cerebrovascular (0.80 versus 0.62x100 person years) events did not differ (all P=NS) between subjects with and without ALVSD. ALVSD is a potent and early marker of evolution toward severe CHF requiring hospitalization in subjects with essential hypertension.


Key words: heart failure • ventricular function, left • echocardiography • hypertrophy • blood pressure monitoring, ambulatory




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators
Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients
Ann Intern Med, September 4, 2007; 147(5): 311 - 319.
[Abstract] [Full Text] [PDF]